2 minute read
Fortress Diagnostics to invest £8m in new headquarters
Fortress Diagnostics has announced that following a period of substantial global growth it is investing over £8 million in new UK headquarters. The firm is a global provider of in vitro diagnostics (IVDs) and provide highly accurate medical testing solutions to immunology, haematology and serological laboratories in hospitals, medical centres, clinics, blood banks and research institutions
Located in Antrim, the brand new custom-built 30,000 square-foot facility will be a centre for research, development and manufacturing. It will support the delivery of over 1,000 diagnostic testing products to more than 100 international markets.
Fortress Diagnostics is investing £8m in a new headquarters that with see the firm double its headcount in the next 3 years / Picture: Fortress Diagnostics
Due to open in early 2020, the new facility will host cutting edge laboratories utilising the latest technology for medical diagnostics. Significant investments have been made in freeze-drying, specialist manufacturing and automation in order to create new product lines, develop new markets and increase manufacturing efficiency.
The investment will also see the company double its headcount over the next three years, creating new roles across a wide range of functions including Scientific Research & Development, Production and Commercial Operations.
Fortress Diagnostics Managing Director Morteza Afrasiabi, said: “Over the past 19 years, our highly skilled scientific team has focused on researching, developing and manufacturing innovative quality diagnostic kits to enable healthcare practitioners across the globe to accurately diagnose often life-changing conditions.
“Due to our continued success we have now outgrown our current facility and this expansion will allow us to increase our manufacturing capacity to meet a significant increase in customer demand.
“The investment in new technologies will also provide our R&D team with the opportunity to place a strong focus on new product development and the optimisation of our existing tests in order to offer the best quality products on the market.”
Rosita Zolnourian, Operations Director at Fortress Diagnostics, added: “This is an exciting time for Fortress Diagnostics. We are looking forward to moving to our new headquarters and expanding our team, which will no doubt contribute to the continuing growth of our company.”